PURPOSE: Colorectal cancer is the second most common cause of cancer death in the United States, and rates of screening for colorectal cancer are low. We sought to gather the perceptions of clinic personnel at Latino-serving Federally Qualified Health Centers (operating 17 clinics) about barriers to utilization of screening services for colorectal cancer. METHOD: We conducted one-on-one interviews among 17 clinic personnel at four Latino-serving Federally Qualified Health Center networks in Oregon. All interviews were recorded, transcribed, and coded, and themes were grouped by influences at three levels: the patient, the organization, and the external environment. RESULTS: Estimated proportions of eligible patients who are underscreened for colorectal cancer ranged from 20% to 70%. Underscreening was thought to occur among low-income, underinsured, and undocumented patients and patients having multiple health concerns. Limited funding to pay for follow-up testing in patients with positive screens was cited as the key factor contributing to underscreening. CONCLUSIONS: We identified health care provider perceptions about the underutilization of screening services for colorectal cancer; our findings may inform future efforts to promote guideline-appropriate cancer screening.
PURPOSE:Colorectal cancer is the second most common cause of cancer death in the United States, and rates of screening for colorectal cancer are low. We sought to gather the perceptions of clinic personnel at Latino-serving Federally Qualified Health Centers (operating 17 clinics) about barriers to utilization of screening services for colorectal cancer. METHOD: We conducted one-on-one interviews among 17 clinic personnel at four Latino-serving Federally Qualified Health Center networks in Oregon. All interviews were recorded, transcribed, and coded, and themes were grouped by influences at three levels: the patient, the organization, and the external environment. RESULTS: Estimated proportions of eligible patients who are underscreened for colorectal cancer ranged from 20% to 70%. Underscreening was thought to occur among low-income, underinsured, and undocumented patients and patients having multiple health concerns. Limited funding to pay for follow-up testing in patients with positive screens was cited as the key factor contributing to underscreening. CONCLUSIONS: We identified health care provider perceptions about the underutilization of screening services for colorectal cancer; our findings may inform future efforts to promote guideline-appropriate cancer screening.
Keywords:
cancer prevention and screening; health behavior; health disparities; health promotion; qualitative methods; race/ethnicity; social determinants; training health professionals
Authors: Nancy K Janz; Indu Lakhani; Sandeep Vijan; Sarah T Hawley; Lynna K Chung; Steven J Katz Journal: Prev Med Date: 2006-12-28 Impact factor: 4.018
Authors: Christina M Getrich; Andrew L Sussman; Deborah L Helitzer; Richard M Hoffman; Teddy D Warner; Victoria Sánchez; Angélica Solares; Robert L Rhyne Journal: Qual Health Res Date: 2011-11-08
Authors: Kimberly M Kelly; Clarenda M Phillips; Crystal Jenkins; Gretchen Norling; Carol White; Todd Jenkins; Debra Armstrong; Joe Petrik; Amy Steinkuhl; Regina Washington; Mark Dignan Journal: Cancer Control Date: 2007-04 Impact factor: 3.302
Authors: Carrie N Klabunde; David Lanier; Marion R Nadel; Caroline McLeod; Gigi Yuan; Sally W Vernon Journal: Am J Prev Med Date: 2009-05-13 Impact factor: 5.043
Authors: Carrie N Klabunde; David Lanier; Erica S Breslau; Jane G Zapka; Robert H Fletcher; David F Ransohoff; Sidney J Winawer Journal: J Gen Intern Med Date: 2007-05-30 Impact factor: 5.128
Authors: Gloria D Coronado; Jennifer L Schneider; Jennifer J Sanchez; Amanda F Petrik; Beverly Green Journal: Transl Behav Med Date: 2015-03 Impact factor: 3.046
Authors: Jennifer K Coury; Jennifer L Schneider; Beverly B Green; Laura-Mae Baldwin; Amanda F Petrik; Jennifer S Rivelli; Malaika R Schwartz; Gloria D Coronado Journal: Transl Behav Med Date: 2020-02-03 Impact factor: 3.046
Authors: Jessica L Krok-Schoen; Michelle L Kurta; Rory C Weier; Greg S Young; Autumn B Carey; Cathy M Tatum; Electra D Paskett Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-10-13 Impact factor: 4.254
Authors: Alicia L Best; Cheryl Vamos; Seul Ki Choi; Erika L Thompson; Ellen Daley; Daniela B Friedman Journal: J Cancer Educ Date: 2017-06 Impact factor: 2.037
Authors: Swann Arp Adams; Catherine L Rohweder; Jennifer Leeman; Daniela B Friedman; Ziya Gizlice; Robin C Vanderpool; Natoshia Askelson; Alicia Best; Susan A Flocke; Karen Glanz; Linda K Ko; Michelle Kegler Journal: J Community Health Date: 2018-12
Authors: Cynthia M Mojica; Savannah M Bradley; Bonnie K Lind; Yifan Gu; Gloria D Coronado; Melinda M Davis Journal: Am J Prev Med Date: 2019-11-28 Impact factor: 5.043
Authors: Amanda F Petrik; Beverly Green; Jennifer Schneider; Edward J Miech; Jennifer Coury; Sally Retecki; Gloria D Coronado Journal: J Gen Intern Med Date: 2020-10-26 Impact factor: 5.128
Authors: Elizabeth N Alpert; Tatiana Clark; Cristian Garcia-Alcaraz; Sumayah Nuhaily Eddington; Claudia Carrizosa; Jessica Haughton; Carolina Lopez de la Torre; Felipe Garcia-Bigley; Elva M Arredondo; Christian Ramers; Jesse Nodora; Kristen J Wells Journal: J Cancer Educ Date: 2021-04-23 Impact factor: 1.771